Cargando…
Assessing measurement invariance in the EORTC QLQ-C30
PURPOSE: We aimed to investigate measurement invariance (MI) in the European Organisation for research and treatment of cancer quality of life questionnaire core 30 (EORTC QLQ-C30) in a heterogeneous sample of patients with cancer. METHODS: Data from 12 studies within the PROFILES registry were used...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921013/ https://www.ncbi.nlm.nih.gov/pubmed/34327634 http://dx.doi.org/10.1007/s11136-021-02961-8 |
_version_ | 1784669243903574016 |
---|---|
author | van Roij, Janneke Kieffer, Jacobien M. van de Poll-Franse, Lonneke Husson, Olga Raijmakers, Natasja J. H. Gelissen, John |
author_facet | van Roij, Janneke Kieffer, Jacobien M. van de Poll-Franse, Lonneke Husson, Olga Raijmakers, Natasja J. H. Gelissen, John |
author_sort | van Roij, Janneke |
collection | PubMed |
description | PURPOSE: We aimed to investigate measurement invariance (MI) in the European Organisation for research and treatment of cancer quality of life questionnaire core 30 (EORTC QLQ-C30) in a heterogeneous sample of patients with cancer. METHODS: Data from 12 studies within the PROFILES registry were used for secondary analyses (n = 7007). We tested MI by successive restrictions on thresholds, loadings, and intercepts across subgroups based on primary cancer sites, age, sex, time since diagnosis, and life stage, using multigroup confirmatory factor analysis (MGCFA) for ordered categorical measures. We also evaluated the impact of potentially miss-specified parameter equality across groups on latent factor means by releasing threshold and loading equality constraints for each item at a time. RESULTS: Results showed that the highest level of MI (invariance of thresholds, loadings, and intercepts) was found across groups based on time since diagnosis and life stage and to a lesser extent across groups based on sex, age, and primary tumor site. On item level, however, changes in the item’s associated factor means were relatively small and in most cases canceled each other out to some extent. CONCLUSIONS: Given only a few instances of non-invariance in our study, there is reason to be confident that valid conclusions can be drawn from between-group comparisons of QLQ-C30 latent means as operationalized in our study. Nonetheless, further research into MI between other subgroups for the QLQ-C30 (i.e., treatment effects and ethnicity) is warranted. We stress the importance of including MI evaluations in the development and validation of measurement instruments. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-021-02961-8. |
format | Online Article Text |
id | pubmed-8921013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-89210132022-03-17 Assessing measurement invariance in the EORTC QLQ-C30 van Roij, Janneke Kieffer, Jacobien M. van de Poll-Franse, Lonneke Husson, Olga Raijmakers, Natasja J. H. Gelissen, John Qual Life Res Article PURPOSE: We aimed to investigate measurement invariance (MI) in the European Organisation for research and treatment of cancer quality of life questionnaire core 30 (EORTC QLQ-C30) in a heterogeneous sample of patients with cancer. METHODS: Data from 12 studies within the PROFILES registry were used for secondary analyses (n = 7007). We tested MI by successive restrictions on thresholds, loadings, and intercepts across subgroups based on primary cancer sites, age, sex, time since diagnosis, and life stage, using multigroup confirmatory factor analysis (MGCFA) for ordered categorical measures. We also evaluated the impact of potentially miss-specified parameter equality across groups on latent factor means by releasing threshold and loading equality constraints for each item at a time. RESULTS: Results showed that the highest level of MI (invariance of thresholds, loadings, and intercepts) was found across groups based on time since diagnosis and life stage and to a lesser extent across groups based on sex, age, and primary tumor site. On item level, however, changes in the item’s associated factor means were relatively small and in most cases canceled each other out to some extent. CONCLUSIONS: Given only a few instances of non-invariance in our study, there is reason to be confident that valid conclusions can be drawn from between-group comparisons of QLQ-C30 latent means as operationalized in our study. Nonetheless, further research into MI between other subgroups for the QLQ-C30 (i.e., treatment effects and ethnicity) is warranted. We stress the importance of including MI evaluations in the development and validation of measurement instruments. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-021-02961-8. Springer International Publishing 2021-07-29 2022 /pmc/articles/PMC8921013/ /pubmed/34327634 http://dx.doi.org/10.1007/s11136-021-02961-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article van Roij, Janneke Kieffer, Jacobien M. van de Poll-Franse, Lonneke Husson, Olga Raijmakers, Natasja J. H. Gelissen, John Assessing measurement invariance in the EORTC QLQ-C30 |
title | Assessing measurement invariance in the EORTC QLQ-C30 |
title_full | Assessing measurement invariance in the EORTC QLQ-C30 |
title_fullStr | Assessing measurement invariance in the EORTC QLQ-C30 |
title_full_unstemmed | Assessing measurement invariance in the EORTC QLQ-C30 |
title_short | Assessing measurement invariance in the EORTC QLQ-C30 |
title_sort | assessing measurement invariance in the eortc qlq-c30 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921013/ https://www.ncbi.nlm.nih.gov/pubmed/34327634 http://dx.doi.org/10.1007/s11136-021-02961-8 |
work_keys_str_mv | AT vanroijjanneke assessingmeasurementinvarianceintheeortcqlqc30 AT kiefferjacobienm assessingmeasurementinvarianceintheeortcqlqc30 AT vandepollfranselonneke assessingmeasurementinvarianceintheeortcqlqc30 AT hussonolga assessingmeasurementinvarianceintheeortcqlqc30 AT raijmakersnatasjajh assessingmeasurementinvarianceintheeortcqlqc30 AT gelissenjohn assessingmeasurementinvarianceintheeortcqlqc30 |